Formularies and Patient Choice: Amazon Pharmacy Executive Calls for Transparency

In the complex world of healthcare, where decisions can have life-altering consequences, the terms "choice" and "transparency" often feel like distant ideals. However, at a recent Bullseye event in Chicago, Tanvi Patel, general manager of Amazon Pharmacy, made a compelling case for why these principles are essential in the pharmacy market.

Patel joined the CEO of a pharmacy benefits manager (PBM) to discuss systemic challenges and misaligned incentives that contribute to high prescription drug prices. Both executives pointed out practices by pharmaceutical companies, PBMs, and other stakeholders that have directly led to Americans paying more for their medications.

"Choice becomes paramount and formulary is anti-choice," Patel stated during the session. She explained that while it might be tempting for a brand manager to push only one medication for a condition-thus benefiting their personal profit and loss (P&L) or goals-this approach ultimately harms consumers. "If you can get your medication and only your medication for a certain condition, you’re going to go for that more and more," she said.

Building a Transparent Marketplace

Patel praised Amazon's efforts to create a transparent marketplace where patients have access to multiple options. "We built a marketplace. We’re transparent on pricing. We have our own products alongside third-party marketplace products on everything," she explained. This transparency, according to Patel, ensures that consumers can make informed decisions based on price and quality.

The current system often fails patients when it comes to formularies-lists of generic and brand-name prescription medications covered by a patient’s or an employee’s health insurance plan or self-insured employer. Patel highlighted a common issue: "If someone gets prescribed a medication and it’s not on their formulary, they get given only a cash price. Now they can’t afford it."

She questioned why patients are not informed about therapeutic alternatives available on their formularies right from the start. "Why are there formularies at all?" Patel asked, challenging the status quo.

The rise of artificial intelligence (AI) in healthcare systems, especially in rural areas, offers a glimmer of hope for improving transparency and access. AI can enhance speed, accuracy, and accessibility, but it must be guided by transparent systems that prioritize patient choice and safety. As one advocate noted on Facebook, "Choice must be informed, safe, and guided by transparent systems."

What Comes Next

The call for more transparent and consumer-friendly practices in the pharmaceutical industry is gaining traction. As healthcare continues to evolve, stakeholders must address the systemic issues that limit patient choice and drive up drug prices.

Patel’s insights at Bullseye highlight a growing movement towards transparency and patient empowerment. By creating marketplaces where consumers have access to multiple options and clear pricing information, the industry can take significant steps toward ensuring that patients receive the care they need without unnecessary financial burden.

In the end, the goal is simple: to build a healthcare system that puts the needs and choices of patients first.